AACP
CLYM

Advantage Alpha Capital Partners’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Advantage Alpha Capital Partners’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48,169
Closed -$245K – 181
2024
Q3 		$245K Buy
+48,169
New +$245K 0.06% 165